NEW YORK–(BUSINESS WIRE)–Surgimate, the leading provider of surgical coordination software in the U.S., today announced the appointment of Kraig Brown as its new CEO. Brown, formerly the CEO of Office Practicum, has a proven track record of helping businesses scale. He brings to Surgimate more than 25 years of executive experience, predominantly in the digital … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “The Role of the Person Responsible for Regulatory Compliance (PRRC) Under the MDR (Medical Device Regulation) and IVDR (In-Vitro Diagnostic Regulation) Training Course” conference has been added to ResearchAndMarkets.com’s offering. Attend this one-day course to gain a comprehensive understanding of the critical role of the Person Responsible for Regulatory Compliance (PRRC) introduced by … [Read more…]
KNOXVILLE, Tenn.–(BUSINESS WIRE)–On January 16, 2025, Neuraly Inc. (Neuraly), a wholly owned subsidiary of D&D Pharmatech Inc., and Enigma Biomedical USA, Inc. (Enigma) announced the signing of a research license and commercialization option agreement for PMI04, a PET (Positron Emission Tomography) imaging biomarker of neuroinflammation developed by Neuraly. Under the agreement, Enigma acquires an exclusive … [Read more…]
ATLANTA–(BUSINESS WIRE)–Mirion (NYSE: MIR) announced today that it will release financial results for fourth quarter and full year 2024 after market close on Tuesday, February 11, 2025. Following the news release, the company will host a conference call the next day, Wednesday, February 12, 2025, at 11:00 am ET to discuss the results. Participants may … [Read more…]
SAN FRANCISCO–(BUSINESS WIRE)–Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2024 after market close on February 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Single-use Technologies for Biopharmaceuticals Market” report has been added to ResearchAndMarkets.com’s offering. The Single-use Technologies for Biopharmaceuticals was valued at USD 6.5 billion in 2024, and is projected to reach USD 11.2 billion by 2029, rising at a CAGR of 11.60%. This report summarizes the single-use technologies market, including a market snapshot and … [Read more…]
Annual Impact Report Now Available, Sharing Key Collaborations, Milestones and Growth, Highlighting New Offerings to Facilitate Whole-Person Care LOUISVILLE, Ky.–(BUSINESS WIRE)–Bamboo Health™, the leader in Real-Time Care Intelligence™, today announced the release of the company’s Annual Impact Report. The report highlights new transformative offerings that enhance outcomes for top healthcare organizations nationwide, improvements in behavioral … [Read more…]
SKILLMAN, N.J.–(BUSINESS WIRE)–Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on Kenvue’s common stock. This quarterly dividend is payable on February 26, 2025, to shareholders of record as of the close of business on February 12, 2025. About Kenvue Kenvue Inc. is the … [Read more…]
MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) releases its total number of shares outstanding as well … [Read more…]
LONG BEACH, Calif.–(BUSINESS WIRE)–$RKLB–Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced its second Pioneer spacecraft for Varda Space Industries, Inc. (“Varda”) is successfully operating on orbit. The mission launched January 14, from Vandenberg Space Force Base at 11:09 PDT (19:09 UTC). … [Read more…]
